SCHEMBL6964397

SCHEMBL6964397

Cc1ccc(S(=O)(=S)OCC=Cc2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.48
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
IDO1 P14902 2/20 0.42
HTT P42858 3/20 0.42
RECQL P46063 1/20 0.39
CYP24A1 Q07973 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP1B1 Q16678 1/20 0.38
CA12 O43570 2/20 0.37
CA9 Q16790 2/20 0.37
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
LMNA P02545 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8664947 0.85 PPARG (0.50) PPARGALDH1A1KDM4EMEN1KMT2A
SCHEMBL8664950 0.85 PPARG (0.50) PPARGALDH1A1KDM4EMEN1KMT2A
Piperazine SCHEMBL11840225 0.80 PPARG (0.45) PPARGALDH1A1KDM4EMEN1KMT2A
SCHEMBL7373803 0.75 C5AR1 (0.42) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL27849267 0.75 IDO1 (0.53) PPARGIDO1CYP24A1LMNANFE2L2
SCHEMBL1169877 0.75 IDO1 (0.53) PPARGIDO1CYP24A1LMNANFE2L2
SCHEMBL11355618 0.74 IDO1 (0.57) PPARGIDO1LMNANFE2L2
SCHEMBL11285547 0.74 IDO1 (0.57) PPARGIDO1LMNANFE2L2
SCHEMBL9432132 0.74 CA9 (0.50) ALDH1A1KMT2AHTTSMN1; SMN2CA12
SCHEMBL9620558 0.74 CTSK (0.58) PPARGALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed